All of the newly diagnosed glioblastoma multiforme patients enrolled in a Phase 1 clinical trial have exceeded both their median and expected progression-free survivals. Two patients, to date, have exceeded their expected overall survival.

According to the Alabama Department of Public Health, Alabama ranks fifth in the United States for oral cavity and pharynx cancer incidence and seventh among the states for oral cavity and pharynx cancer deaths.

UAB has been awarded for its superior CAR-T therapy program services and leadership.

A UAB study shows that bone marrow transplant recipients have a shorter lifespan as compared to their counterparts.

UAB patients with stage 4 cancer now have more options for treatments.

A new study confirms that G207, a genetically engineered virus developed at UAB, may be a beneficial therapy for brain tumors.

The infusion therapy can help shrink tumors that are otherwise inoperable.

Because the beam of photons is so tightly focused, proton therapy has little effect on surrounding healthy tissue, making it especially beneficial for young patients.

The NIH grant creates Multiple Chronic Disease Centers around the nation to target chronic disease in minority populations.

Blood and marrow transplantation strategies have changed significantly over the past four decades; but recipients still experience excess mortality that translates into 8.7 years of life lost, according to researchers in UAB’s Institute for Cancer Outcomes and Survivorship.

Limiting neuroinflammation may represent a promising new approach to treat neurological diseases driven by neuroinflammation, such as stroke, spinal cord injury and neuropathic pain.

This finding upends the long-held paradigm that priming during lung infections takes place only in the draining lymph nodes, and it will be key to developing more efficient vaccinations and therapies for respiratory challenges.

Adaptive radiation therapy allows for more precise treatment by fine-tuning the treatment regimen based on up-to-date imaging.

New findings include a significant increase in risk of death among patients who had recently had chemotherapy.

G207, an immunotherapy derived from a modified herpes virus is well tolerated in children with gliomas, and shows signs of clinical effectiveness

The list was made by a group that aspires to bolster and increase diversity across all scientific fields, promote retention through the “leaky academic pipeline,” and broaden academic and industrial awareness of diversity and inclusion.

Warner K. Huh, M.D., will assume the role of OBGYN chair in the UAB School of Medicine on Nov. 1.

This study was done in mice and with a novel, tissue-engineered, three-dimensional breast cancer mimetic system.

The alliance will utilize innovative strategies to address health disparities, mental and behavioral health, and diabetes, with an emphasis on expanded access for poor, vulnerable and rural populations.

UAB and Proton International open the first proton therapy center for cancer treatment in Alabama.